The biotechnology market is expected to show substantial growth over the forecast period owing to regulatory support offered to various companies operating in the biotechnology field. In addition, the increased demand for food in developing countries has spurred the growth of the bioagriculture market. Bioseeds are expected to show exponential growth as compared to conventional seeds over the forecast period.

This report on the biotechnology market analyzes and estimates the global revenue generated by the biotechnology industry over the forecast period i.e. 2012 to 2017. The scope of the report considers biotechnology to be divided into four primary segments namely biopharmacy, bioservices, bioagriculture and bioindustrial. In terms of technology, the biotechnology market has been segmented into fermentation, tissue regeneration, PCR technology, nanobiotechnology, chromatography, DNA sequencing, cell based assay and others. The others segment comprises of genetic engineering, enzyme technology and fingerprinting among others.

Biopharmacy comprises of various pharmaceuticals manufactured by using biotechnology and also covers medical devices. The bioservices segment predominantly comprises of CROs (Contract Research Organizations) which are third party organizations performing clinical trials, drug discovery and contract manufacturing. The bioindustrial application includes the use of bioenzymes and biochemicals for a variety of chemical processes. Bioagriculture comprises of bioseeds and genetically modified (GM) crops.

The study explains the various drivers and restraints affecting the market along with the impact they would have over the forecast period. A detailed analysis of the opportunities available in the market over the next five years has also been included. The value chain for the biotechnology market has been provided for a better understanding of the process followed in the market. The study covers in detail the Porters Five Forces analysis, which gives the users of this report a better perspective into the present and future market scenarios. The market has been segmented based on technology, application and geography. Apart from the global application overview, the report further segregates the applications for regions such as North America, Europe, Asia Pacific and Rest of the World (RoW).

Key market players in the report include Roche, Amgen, Novo Nordisk, Sanofi and Pfizer among others. A detailed company market share has been included to give a better understanding of the competitive situation in the market. In addition, these companies have been profiled with respect to attributes such as company overview, financial overview, SWOT analysis, business strategy and recent developments.

Biotechnology Market, by Technology:
Fermentation
Tissue regeneration
PCR technology
Nanobiotechnology
Chromatography
DNA sequencing
Cell based assay
Others

Biotechnology Market, by Application:
Biopharmacy
Bioservices
Bioagriculture
Bioindustrial

The report provides a cross-sectional analysis of all the above applications with respect to the following geographical markets:
North America
Europe
Asia Pacific
Rest of the World (RoW)

The detailed analysis and research will help biotechnology companies, retailers and R&D institutes to make well-informed decisions about manufacturing, marketing and sales and in turn help them gain competitive advantage.

Table Of Contents

TABLE OF CONTENTS

Chapter 1 Preface
1.1 Report Description
1.2 Research Methodology

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Introduction
3.2 Value Chain Analysis
3.3 Market Drivers
3.3.1 Regulatory Support
3.3.2 Increasing Food Demand
3.3.3 Limited Availability of Non-Renewable Natural Resources
3.4 Market Restraints
3.4.1 Ethical Issues Associated with Clinical Trials
3.4.2 Long Research and Development Lead Time
3.5 Market Opportunities
3.5.1 Emergence of Biosimilars
3.5.2 Biotechnology in Medical Sciences
3.6 Porters Five Force Analysis
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Threat of New Entrants
3.6.4 Threat from Substitutes
3.6.5 Degree of Competition
3.7 Biotechnology: Company Market Share Analysis
3.8 Biotechnology: Market Attractiveness Analysis
3.8.1 Biotechnology Market, by Application: Attractiveness Analysis
3.8.2 Biotechnology Market, by Technology: Attractiveness Analysis

Chapter 4 Global Biotechnology Market, by Application
4.1 Global Biotechnology Market: Application Overview
4.1.1 Global Biotechnology Market Revenue Share, by Application, 2010 and 2017
4.2 Biotechnology Market, by Application, 2010 - 2017
4.2.1 Biopharmacy
4.2.1.1 Global Biopharmacy Market, 2010 - 2017 (USD Billion)
4.2.2 Bioservices
4.2.2.1 Global Bioservices Market, 2011 - 2017 (USD Billion)
4.2.3 Bioagriculture
4.2.3.1 Global Bioagriculture Market, 2010 - 2017 (USD Billion)
4.2.4 Bioindustrial
4.2.4.1 Global Bioindustrial Market, 2011 - 2017 (USD Billion)

Chapter 5 Global Biotechnology Market, by Technology
5.1 Global Biotechnology Market Overview, by Technology
5.1.1 Global Biotechnology Market Revenue Share, by Technology, 2010 And 2017
5.2 Fermentation Technology
5.2.1 Global Fermentation Technology Market, 2010 - 2017 (USD Billion)
5.3 Tissue Engineering And Regeneration Technology
5.3.1 Global Tissue Engineering and Regeneration Technology Market, 2010 - 2017 (USD Billion)
5.4 Polymerase Chain Reaction (PCR) Technology
5.4.1 Global PCR Technology Market, 2010 - 2017 (USD Billion)
5.5 Nanobiotechnology
5.5.1 Global Nanobiotechnology Market, 2010 - 2017 (USDBillion)
5.6 Chromatography
5.6.1 Global Chromatography Market, 2010 - 2017 (USD Billion)
5.7 Dna Sequencing Technology
5.7.1 Global DNA Sequencing Technology Market, 2010 - 2017 (USD Billion)
5.8 Cell Based Assay
5.8.1 Global Cell Based Assay Market, 2010 - 2017 (USD Billion)
5.9 Others (Enzyme Technology, Finger Printing, Etc.)
5.9.1 Global Other Technologies Market, 2010 - 2017 (USD Billion)

Chapter 6 Global Biotechnology Market, by Geography
6.1 Global Biotechnology Market Overview, by Geography
6.1.1 Global Biotechnology Market Revenue Share,by Geography, 2011 and 2017
6.2 North America
6.2.1 North America Market for Biotechnology, 2010 - 2017, (USD Billion)
6.2.2 North America Market Demand For Biotechnology, By Application, 2010 - 2017, (USD Billion)
6.2.2.1 Demand for Biopharmacy in North America, 2010 - 2017, (USD Billion)
6.2.2.2 Demand for Bioservices in North America, 2010 - 2017, (USD Billion)
6.2.2.3 Demand for Bioagriculture in North America, 2010 - 2017, (USD Billion)
6.2.2.4 Demand for Bioindustrial Products in North America, 2010 - 2017, (USD Billion)
6.3 Europe
6.3.1 Europe Market for Biotechnology, 2010 - 2017, (USD Billion)
6.3.2 Europe Market Demandfor Biotechnology, by Application, 2010 - 2017, (USD Billion)
6.3.2.1 Demandfor Biopharmacyin Europe, 2010 - 2017, (USD Billion)
6.3.2.2 Demand for Bioservices in Europe, 2010 - 2017, (USD Billion)
6.3.2.3 Demand for Bioagriculture in Europe, 2010 - 2017, (USD Billion)
6.3.2.4 Demand for Bioindustrial Products in Europe, 2010 - 2017, (USD Billion)
6.4 Asia Pacific
6.4.1 Asia Pacific Market for Biotechnology, 2010 - 2017, (USD Billion)
6.4.2 Asia Pacific Market Demandfor Biotechnology, by Application, 2010 - 2017, (USD Billion)
6.4.2.1 Demand for Biopharmacy in Asia Pacific, 2010 - 2017, (USD Billion)
6.4.2.2 Demand For Bioservices in Asia Pacific, 2010 - 2017, (USD Billion)
6.4.2.3 Demand For Bioagriculture in Asia Pacific, 2010 - 2017, (USD Billion)
6.4.2.4 Demand For Bioindustrial Products in Asia Pacific, 2010 - 2017, (USD Billion)
6.5 Rest Of World
6.5.1 Rest of World Market for Biotechnology, 2010 - 2017, (USD Billion)
6.5.2 Rest Of World (Row) Market Demand for Biotechnology, by Application, 2010 - 2017, (USD Billion)
6.5.2.1 Demandfor Biopharmacy in Row, 2010 - 2017, (USDBillion)
6.5.2.2 Demand for Bioservices in Row, 2010 - 2017, (USD Billion)
6.5.2.3 Demand for Bioagriculture in Row, 2010 - 2017, (USD Billion)
6.5.2.4 Demand for Bioindustrial Products in Row, 2010 - 2017, (USD Billion)

Chapter 7 Company Profile
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Business Strategies
7.1.4 Swot Analysis
7.1.5 Recent Developments
7.2 Amgen Inc.
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.2.4 Swot Analysis
7.2.5 Recent Developments
7.3 Glaxosmithkline
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.3.4 Swot Analysis
7.3.5 1.3.5 Recent Developments
7.4 Johnson And Johnson
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Business Strategy.
7.4.4 Swot Analysis
7.4.5 Recent Developments
7.5 Merck
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Business Strategy
7.5.4 Swot Analysis
7.5.5 Recent Developments
7.6 Novartis
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Business Strategy
7.6.4 Swot Analysis
7.6.5 Recent Developments
7.7 Novo Nordisk
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Swot Analysis
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Pfizer (Wyeth)
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Business Strategies.
7.8.4 Swot Analysis
7.8.5 Recent Developments
7.9 Roche
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Business Strategies
7.9.4 Swot Analysis
7.9.5 Recent Developments
7.10 Sanofi - Aventis
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Business Strategy
7.10.4 Swot Analysis
7.10.5 Recent Developments
7.11 Lonza Group Ltd.
7.11.1 Company Overview
7.11.2 Financial Overview
7.11.3 Business Strategy
7.11.4 Swot Analysis
7.11.5 Recent Developments
7.12 Biogen Idec Inc
7.12.1 Company Overview
7.12.2 Financial Overview
7.12.3 Business Strategy
7.12.4 Swot Analysis
7.12.5 Recent Developments
7.13 1.13 Astra Zeneca
7.13.1 Company Overview
7.13.2 Financial Overview
7.13.3 Business Strategy
7.13.4 Swot Analysis
7.13.5 Recent Developments
7.14 Genentech
7.14.1 Company Overview
7.14.2 Financial Overview
7.14.3 Business Strategies
7.14.4 Swot Analysis
7.14.5 Recent Developments
7.15 Genzyme
7.15.1 Company Overview
7.15.2 Financial Overview
7.15.3 Swot Analysis
7.15.4 Recent Developments
7.16 Gilead Sciences
7.16.1 Company Overview
7.16.2 Financial Overview
7.16.3 Swot Analysis
7.16.4 Business Strategies
7.16.5 Recent Developments
7.17 Celgene
7.17.1 Company Overview
7.17.2 Financial Overview
7.17.3 Business Strategy
7.17.4 Swot Analysis
7.17.5 Recent Developments



LIST OF FIGURES

Fig. 1 Global Biotechnology Market, 2010 - 2017, (USD Billion)
Fig. 1 Biotechnology Industry: Value Chain Analysis
Fig. 2 World Population Growth, Billion, 2006 - 2012
Fig. 3 Bioseeds Vs. Conventional Seeds Market Demand, USD Million, 2006 - 2011
Fig. 4 Global Crude Oil Price Trend Estimate And Forecast, 2009 - 2018 (USD/Barrel)
Fig. 5 World Biofuel Production, Billion Liters, 2009 - 2018
Fig. 6 Region Split Of Victims Of Lax Clinical Trials, 2011
Fig. 7 Stages Involved In Drug Approval
Fig. 8 Porters Five Forces Analysis
Fig. 9 Biotechnology : Company Market Share, 2011
Fig. 10 Biotechnology Market, By Application: Attractiveness Analysis 2011
Fig. 11 Biotechnology Market, By Application: Attractiveness Analysis, 2011
Fig. 12 Global Biotechnology Market Revenue Share, By Application, 2011 And 2017
Fig. 13 Global Biopharmacy Market, 2010 - 2017 (USD Billion)
Fig. 14 Global Bioservices Market, 2011 - 2017 (USD Billion)
Fig. 15 Global Bioagriculture Market, 2010 - 2017 (USD Billion)
Fig. 16 Global Bioindustrial Market, 2011 - 2017 (USD Billion)
Fig. 17 Global Biotechnology Market Revenue Share, By Technology, 2011 And 2017
Fig. 18 Global Fermentation Technology Market, 2010 - 2017 (USD Billion)
Fig. 19 Global Tissue Engineering And Regeneration Technology Market, 2010 - 2017 (USD Billion)
Fig. 20 Global PCR Technology Market, 2010 - 2017 (USD Billion)
Fig. 21 Global Nanobiotechnology Market, 2010 - 2017 (USD Billion)
Fig. 22 Global Chromatography Market, 2010 - 2017 (USD Billion)
Fig. 23 Global Dna Sequencing Technology Market, 2010 - 2017 (USD Billion)
Fig. 24 Global Cell Based Assay Market, 2010 - 2017 (USD Billion)
Fig. 25 Global Other Technologies Market, 2010 - 2017 (USD Billion)
Fig. 26 Global Biotechnology Market Revenue Share, By Geography, 2011 And 2017
Fig. 27 North America Market For Biotechnology, 2010 - 2017, (USD Billion)
Fig. 28 Demand For Biopharmacy In North America, 2010 - 2017, (USD Billion)
Fig. 29 Demand For Bioservices In North America, 2010 - 2017, (USD Billion)
Fig. 30 Demand For Bioagriculture In North America, 2010 - 2017, (USD Billion)
Fig. 31 Demand For Bioindustrial Products In North America, 2010 - 2017, (USD Billion)
Fig. 32 Europe Market For Biotechnology, 2010 - 2017, (USD Billion)
Fig. 33 Demand For Biopharmacy In Europe, 2010 - 2017, (USD Billion)
Fig. 34 Demand For Bioservices In Europe, 2010 - 2017, (USD Billion)
Fig. 35 Demand For Bioagriculture In Europe, 2010 - 2017, (USD Billion)
Fig. 36 Demand For Bioindustrial Products In Europe, 2010 - 2017, (USD Billion)
Fig. 37 Asia Pacific Market For Biotechnology, 2010 - 2017, (USD Billion)
Fig. 38 Demand For Biopharmacy In Asia Pacific, 2010 - 2017, (USD Billion)
Fig. 39 Demand For Bioservices In Asia Pacific, 2010 - 2017, (USD Billion)
Fig. 40 Demand For Bioagriculture In Asia Pacific, 2010 - 2017, (USD Billion)
Fig. 41 Demand For Bioindustrial Products In Asia Pacific, 2010 - 2017, (USD Billion)
Fig. 42 Rest Of World Market For Biotechnology, 2010 - 2017, (USD Billion)
Fig. 43 Demand For Biopharmacy In Row, 2010 - 2017, (USD Billion)
Fig. 44 Demand For Bioservices In Row, 2010 - 2017, (USD Billion)
Fig. 45 Demand For Bioagriculture In Row, 2010 - 2017, (USD Billion)
Fig. 46 Demand For Bioindustrial Products In Row, 2010 - 2017, (USD Billion)



LIST OF TABLES

Table 1 Biotechnology Market: Global Snapshot
Table 2 Drivers For Biotechnology Market: Impact Analysis
Table 3 Restraints For Biotechnology Market : Impact Analysis

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Global Next-generation Sequencing Market

Global Next-generation Sequencing Market

  • $ 10 000
  • Industry report
  • June 2014
  • by Frost & Sullivan

On the Verge of a Quadrupled Competitor Size and a Clinical Turning Point The total market, as defined by this study, includes next-generation sequencing instruments and reagents. Instruments include those ...

Sample Preparation Market by Product [Instruments (Workstations, Liquid Handling Systems), Consumables (Tubes), Kits (Isolation, Purification)], Application (Genomics, Proteomics) & by End Users (Molecular Diagnostics) - Global Forecast to 2018

Sample Preparation Market by Product [Instruments (Workstations, Liquid Handling Systems), Consumables (Tubes), Kits (Isolation, Purification)], Application (Genomics, Proteomics) & by End Users (Molecular Diagnostics) - Global Forecast to 2018

  • $ 4 650
  • Industry report
  • May 2014
  • by MarketsandMarkets

Over the years, the sample preparation market, comprising of instruments, consumables, accessories and kits, has witnessed various technological advancements. These advancements have led to a growth in ...

Metabolomics Market by Technique, Application & by Indication - Global Forecast to 2019

Metabolomics Market by Technique, Application & by Indication - Global Forecast to 2019

  • $ 4 650
  • Industry report
  • June 2014
  • by MarketsandMarkets

In this report, the global metabolomics market is segmented based on techniques, applications, indications, and geography. Based on techniques, the metabolomics market is classified into Gas Chromatography, ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.